The pharmaceutical giant Eli Lilly’s stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.Read More
Share this:
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on X (Opens in new window) X
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr